SCHEMBL6173987

SCHEMBL6173987

CC(C)Nc1cnccc1CC1(C)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.45
AOC1 P19801 2/20 0.38
AOC3 Q16853 2/20 0.38
NTRK1 P04629 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172473 0.86 IGF1R (0.42) IGF1RNTRK1
SCHEMBL6174742 0.86 IGF1R (0.40) IGF1RNTRK1
SCHEMBL6172191 0.85 AOC1 (0.38) AOC1AOC3NTRK1
SCHEMBL6172456 0.85 IGF1R (0.42) IGF1RNTRK1
SCHEMBL6174374 0.85 IGF1R (0.48) IGF1RNTRK1
SCHEMBL6174069 0.85 IGF1R (0.48) IGF1R
SCHEMBL6175503 0.85 IGF1R (0.48) IGF1RNTRK1
SCHEMBL6176020 0.85 IGF1R (0.40) IGF1RAOC1AOC3
SCHEMBL6173351 0.84 IGF1R (0.41) IGF1RNTRK1
SCHEMBL6172562 0.84 IGF1R (0.47) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed